NBCA LIQUID EMBOLIC SYSTEM 2 631500

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2012-11-20 for NBCA LIQUID EMBOLIC SYSTEM 2 631500 manufactured by Cordis Neurovascular, Inc..

Event Text Entries

[3046492] Pediatric patient treated and discharged with a small rash on his feet. The patient developed a fever and was re-admitted to the hospital. Patient was referred to allergist upon request from his mother. Rep received phone call to alert of the incident on and requested a sample kit for evaluation. Evaluation kit for allergist, under supervision of physician sent to hospital via representative. (b)(4), lot 268818. No date established yet for test. Update will be provided as soon as they are available. Additional information received indicated that the patient was treated with one kit of nbca glue for avm. Patient had a fever and rash like symptoms that the physician suspected may be an allergy to nbca (either cyanoacrylate or ethiodized oil). Physician has not conclusively proven this at this time. The product did not expire.
Patient Sequence No: 1, Text Type: D, B5


[10294000] (b)(4). The product will be returned for evaluation and testing. Additional information will be submitted within 30 days upon receipt.
Patient Sequence No: 1, Text Type: N, H10


[10635924] This (b)(6) male was treated with one kit of trufill nbca liquid embolic system ((b)(4)/lot unknown) for an arteriovenous malformation (avm). The patient had a fever and rash like symptoms that the physician suspected may be an allergy to nbca (either cyanoacrylate or ethiodized oil). The patient was discharged two days post procedure with a small rash on his feet and then was re-admitted the following day with a fever. The patient was then referred to an allergist for evaluation and a trufill kit for evaluation ((b)(4)/lot 268818) was supplied for evaluation under supervision of a physician. Additional follow-up information reported that the results of the allergy testing found that he was not allergic to nbca; they are not sure what caused the allergic reaction. The patient has since had follow-up treatment using nbca to obliterate the last of the avm. One month after this follow-up treatment there has been no sign of allergic reaction. The nbca remains implanted and the lot number is not available; therefore, the device history records review cannot be completed. The instructions for use outlines that allergic reaction is an adverse event which may be associated with embolization procedures (including those observed during the (b)(4) study) and may occur at any time during or after the procedure. The follow-up information reported negative allergy testing with an nbca test kit and follow-up treatment with nbca without any reaction. Additionally based on this, it was reported that it was determined that although the cause of the reported suspected allergic reaction is not known, it was not related to the nbca. Therefore, no corrective actions will be taken at this time.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1058196-2012-00420
MDR Report Key2840124
Report Source05,07
Date Received2012-11-20
Date of Report2012-11-02
Date of Event2012-09-30
Date Mfgr Received2013-03-05
Date Added to Maude2012-11-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. MATTHEW KING
Manufacturer CityMIAMI LAKES FL 33014-280
Manufacturer Postal33014-2802
Manufacturer Phone88283106
Manufacturer G1CORDIS CORPORATION
Manufacturer Street14201 NW 60TH AVE
Manufacturer CityMIAMI LAKES FL 33014-28
Manufacturer Postal Code33014-280
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNBCA LIQUID EMBOLIC SYSTEM 2
Generic NameCNV_NBCA (MFE)
Product CodeKGG
Date Received2012-11-20
Model NumberNA
Catalog Number631500
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCORDIS NEUROVASCULAR, INC.
Manufacturer Address14700 NW 57TH COURT MIAMI LAKES FL 33014 US 33014


Patients

Patient NumberTreatmentOutcomeDate
10 2012-11-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.